ntor Claude invents a toothbrush, documents his invention, works on it does not file an application
--> One month later, Claude writes on his blog and discusses his invention.
--> 2 months later, Inventor Jerry invents the same toothbrush, and files a patent application
--> One month later, Claude files an application for his invention.
Under this scenario, with the new AIA "first to file" system, Claude would be awarded the patent, based on the fact that he was the first to publicly disclose the invention.
Thus, now the most important question is not who created the invention first, but rather, who talked about it first OR who submitted an application first. A public disclosure becomes the "date" that prevents any other inventor or company from receiving a patent on the same invention, even if that inventor or company created the invention prior to the disclosure date. The same thing applies to filing an application. In the absence of any public disclosure, the date of filing an application becomes the "date" that precludes any other inventor or company from obtaining a patent, even if they created the invention prior to the application date.
You can follow Wysebridge Patent Bar Review using a variety of social media sites, including Twitter, Facebook, and
Page: 1 2 3 4 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Enbrel® (etanercept) Patent Issued2
. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office3
. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations4
. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents5
. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions6
. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications7
. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™8
. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain9
. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents10
. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space11
. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology